Table 3.
Demographic, clinical, and treatment information of patients.
| Optical PKP | Therapeutic PKP | p-value | |
|---|---|---|---|
| Sex | 0.073† | ||
| Male, n (%) | 10(40%) | 45(64%) | |
| Female, n (%) | 15(60%) | 17(36%) | |
| Age, years | 49.10 ± 15.27 | 53.73 ± 10.81 | 0.073† |
| Symptom duration, months | 85.32 ± 113.70 | 2.05 ± 6.26 | <0.001† |
| BCVA, logMAR | 1.90 ± 0.48 | 2.07 ± 0.45 | 0.626† |
| IOP, mmHg | 13.12 ± 5.64 | 12.70 ± 8.07 | 0.774† |
| Congestion score | 0.44 ± 0.67 | 2.54 ± 0.71 | <0.001† |
| Ulcer invasive scale, diameter in mm | 4.49 ± 3.52 | 5.86 ± 1.74 | |
| Ulcer invasive scale score | 1.90 ± 0.88 | 2.06 ± 0.53 | 0.251† |
| Depth of Invasion score | 1.39 ± 1.39 | 2.43 ± 0.92 | <0.001† |
| Planting bed diameter, in mm | 7.44 ± 0.31 | 8.05 ± 0.85 | <0.001† |
| Graft size, mm | 7.93 ± 0.30 | 8.5 ± 0.86 | <0.001† |
| Femtosecond laser-assisted | 0.005‡ | ||
| Yes | 12 (28.57%) | 5 (8.06%) | |
| No | 30 (71.43%) | 57 (91.94%) |
†One-way ANOVA test. ‡Chi-squared test.